Author: SG ThumbTack investor

Guest Post: Visa By Datascienceinvestor

Title’s self explanatory… “J” from Datascienceinvestor asked to exchange guest posts, but since I hardly bother to post much myself here these days, I declined, but offered to give him a guest post instead. “J” asked for suggestions, and since my last post was on the top 5 generals for my new fund, I suggested any 1 of the 5 names and he picked Visa. (TTI’s Top 5 Generals) So without further ado, go check his site out. I did, and it’s……. different, I guess. Something refreshing for a change. See if you find this useful. Some of the...

Read More

TTI’s Top 5 Generals

To concentrate? Or to diversify? This has really been on my mind a lot lately. Buffett says diversification is just an insurance against ignorance. Which is really a fancy way of saying that if you’re not entirely sure, or if you think you are sure but am concerned that the world may throw you a curveball, then diversification would help cushion any potential road bumps. But it works both ways. I don’t think it’s possible to get really really amazing returns in the long run if one diversifies too much. Ackman’s Pershing square has what… $10billion under management? And...

Read More

Talent Recruitment For Asia Genesis Asset Management!

After a long hiatus, this is probably going to be a short, but I’m pretty sure, a very much impactful post. Some time ago, I wrote a post about a friend, and that post has been viewed umpteen times (like literally tens of thousands!): Lessons From A Super Investor – A Personal Friend Of TTI More recently, I wrote about Mr Chua restarting his fund: TTI’s Portfolio Updates – End July 2019 + The Thanos Of Global Macro Funds Is Coming Back! Well, today’s post is a recruitment exercise for any talented, smart traders out there who would like...

Read More

Best Robo Advisors In Singapore By ValueChampion

I guess I owe Carrie Arndt from ValueChampion an apology. Having agreed/promised to put up ValueChampion’s post on the rankings of various Robo advisors almost 1 month ago, this post is terribly delayed. In fact, this post must come as a surprise to Carrie cos I haven’t replied the last email for weeks, which is uncharacteristically rude of TTI. Truth is, the year end is usually crazy busy for me, so much so that I think everybody can see there’s been a dearth of updates here. Even my health’s taken a beating as a result. Investing wise has been...

Read More

Moment Of Silence Please.

I’ve previously written several times about the absurdity of Beyond Meat’s valuations, and what the market thinks the company would do. To Infinity & Beyond? Nah! I’ve also been shorting BYND by selling naked calls on it for the past several months, and BYND has been extremely well behaved, going in an almost linear fashion downwards. I’ve answered some queries on shorting BYND, and have also put up some of my short options (the ones that haven’t expired then): +1,680% In 4 Years! Yet, tonight, it all comes to a head. BYND’s top shareholders and insider’s shares lock-up expires...

Read More

+1,680% In 4 Years!

No, silly. That’s not my performance. I wish. As my posts get far and infrequent, each would naturally be a mish mash of several stuff that’s unrelated. So, of course, I’d choose the 1 with the most attention grabbing headline. It’s not scammish though… I’m featuring a friend’s performance. More on that later… @Homan (From the comments section) Here’s the screenshot that I couldn’t attach to the comments section then. So I’m attaching them here for you: So yea, pretty far OTM. All obviously expired now. (In fact, I could’ve doubled my premiums earned if I was a tad...

Read More

To Infinity & Beyond? Nah!

Happy Mid Autumn Festival Guys! I’ve come to realize that since my investing thesis on Avenue Therapeutics (Avenue Therapeutics – No Pain, Lots Of Gain?), I suddenly have a band of American readers/fellow investors/subscribers. Apparently, a friend highlighted to me that if you google Avenue Therapeutics, SG TTI’s post on the company is in the 4th link (thereabouts). Since then, I’ve had a few emails from global readers. This is interesting to me as it’s a fresh and different perspective. Plus I think, most local investors don’t actually understand the thesis that much. So… to the global readers who...

Read More

TTI’s Portfolio Updates – End July 2019 + The Thanos Of Global Macro Funds Is Coming Back!

It’s been 2 months since the last update, and frankly, I’m just going to sorta rush through this post as well. Don’t intend to spend too much time here. So here goes. As a continuation of the last post (TTI’s Portfolio Performance – May 2019 + Avenue Therapeutics Updates): SG Markets Total portfolio value in SG markets is SGD 291,294. As stated at the end of 2018, I set out to shift my activities into global markets. The direction is clear, and I think I’ve executed on my plan thus far, shrinking the SG portfolio part to a fraction of...

Read More

TTI’s Portfolio Performance – May 2019 + Avenue Therapeutics Updates

May 2019’s a tough month, and no, there’s no new “Best. May. Ever” series… (Continuation of these:) Best. January. Ever. Best. February. Ever. Best. Mar……….. You Know The Drill! TT Portfolio Performance & Review Like most of everyone else, TTI’s portfolio ROI declined in May, alongside the volatility and market uncertainties from the trade wars. SG Markets Total portfolio value in SG markets is SGD 357,660. Again, not much activity here, took profit on a tiny itsy bit of Geo Energy to redeploy into US markets, otherwise, holdings remain the same. I’m also not really spending much time looking...

Read More

Avenue Therapeutics – No Pain, Lots Of Gain?

In an earlier post, I posted a teaser for a new investing thesis: Best. Mar……….. You Know The Drill! Yup, the numbers look absolutely horrendous: The company has no revenue, and losses are chalking up y-o-y. Balance sheet looks terrible too. Negative equity! Ouch. So why is TTI even bothering to look into this, much less take up a position? Here’s the story. And it’s going to be a long one. AVENUE THERAPEUTICS Background Now, this investing thesis is likely going...

Read More

Portfolio Divergence From Benchmarks – Thanks Trump!

The 1 major headline in the past few days has certainly been all about the US-China trade negotiations and Trump’s threat to hike tariffs 2 days from now. In the midst of all the uncertainty, the global markets have been roiled and US markets have taken a tumble this week. Whilst I have not predicted this, and neither do I try to, my US portfolio has benefited and continued it’s relentless upward march, even while the world burns and the indices FINALLY start turning down: Finally. Everything starts turning red for once. Everything except TTI’s portfolio. Hitting a new...

Read More

TT Portfolio Performance & Review

Just realized that my last overall portfolio performance update was back in June 2018, and I haven’t been updating it for the past 10 months. The page is now updated and revamped. I’ve added in a line chart of the portfolio size, going back to 2011 since I’ve started tracking. Note that this includes any capital injections or withdrawals. (Mostly injections, except for 2015 and thus far, in 2019). I’ve opted not to add to the portfolio thus far in 2019, as I’ve shunted some capital into the property fund instead. Hopefully, there’d be some firesales that come up...

Read More

Best. Mar……….. You Know The Drill!

Oh Boy. I really could get used to this. 1 post every mth, “Best ____ Ever” everytime. I’d let the stats do the talking: With yesterday’s massive rise, a huge 15.61% portfolio gain in a single day, the ROI has shot up to 37.76% YTD. NAV sits at USD 606,056.73, crossing the USD 600k mark for the 1st time (For US portfolio), with no capital injections too. Taking into account a withdrawal of USD16.90, the total net capital gains YTD is… USD 165,001.13!  EDIT: Did math wrongly. With a withdrawal of USD 16.90, the total net capital gains should...

Read More

Best. February. Ever.

OK, not exactly. It’s more like best YTD ever. And that’s only for US/Global portfolio. But I wanted a title for this post that’s a continuation of: Best. January. Ever. You know… kinda like how some stamps come in a set or a series. A picture speaks a mod-zillion words: I’ve said at the 22% mark that I’d be happy to close the year with that sorta returns. Then, I’ve said at the 28% mark at end Jan, that I probably should close out all positions and do nothing for the rest of the year. Yet, as of end...

Read More

APAC Realty – Acquisition Of ERA Centre Is Cashflow Negative

Well, at least until October 2023. But first, let me state that this post is not exactly a discussion on APAC Realty. I don’t own APAC Realty’s shares, I traded it twice, and was fortunate to walk away with a mere couple of grand in profits, but that’s about it. This is specifically, a discussion of APAC’s recent acquisition of Hersing Centre. (And the numbers behind it) On the 10th Sept 2018, APAC completed the acquisition of Hersing Centre, situated in Toa Payoh, and renamed it ERA Centre. The plan is to use ERA Centre as the headquarters, while...

Read More

Recent Comments

Latest News from PR Newswire